Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 5,743 | 5,401 | 5,072 | 5,495 | 6,058 |
| Cost of Goods | 10,716 | 7,261 | 12,805 | 6,175 | 30,780 |
| Gross Profit | -4,973 | -1,860 | -7,733 | -680 | -24,722 |
| Operating Expenses | 11,285 | 5,596 | 3,647 | 7,235 | 3,119 |
| Operating Income | -16,258 | -7,456 | -11,380 | -7,915 | -27,841 |
| Interest Expense | -23 | 236 | 564 | 9,729 | 4,678 |
| Other Income | -5,524 | 206 | 368 | 3,777 | 1,643 |
| Pre-tax Income | -21,759 | -7,486 | -11,576 | -13,867 | -30,876 |
| Income Tax | 7 | -130 | 236 | 0 | 75 |
| Net Income Continuous | -21,766 | -7,356 | -11,812 | -13,867 | -30,951 |
| Net Income | $-21,766 | $-7,356 | $-11,812 | $-13,867 | $-30,951 |
| EPS Basic Total Ops | -0.08 | -0.03 | -0.05 | -0.07 | -0.22 |
| EPS Basic Continuous Ops | -0.08 | -0.03 | -0.05 | -0.07 | -0.22 |
| EPS Diluted Total Ops | -0.08 | -0.03 | -0.05 | -0.07 | -0.22 |
| EPS Diluted Continuous Ops | -0.08 | -0.03 | -0.05 | -0.07 | -0.22 |
| EBITDA(a) | $-19,399 | $-6,356 | $-9,532 | $-3,262 | $-19,006 |